1401 paras), and to attend a clinic or return the questionnaire after three months. Fifty-two patients (87 %) (15 primiparas and 37 multiparas) completed questionnaires. They were matched with a control group of 52 vaccinated patients who received no hormonal treatment. The mean (i SD) number of days of postpartum bleeding was 58-5 i 18-5 in the treated patients and 20-8 1-1 in the controls. This difference was significant (P <0-001). Patients still bleeding at three months were treated with low-dose oestrogen/ progestogen pills) which invariably stopped bleeding. Only one patient was so treated before three months. Thirty-three treated patients, but only two controls, had continuous bleeding for three months. In no case was the loss heavy and no patients developed anaemia (haemoglobin less than 10-0 g/dl).
Previous reports' 2 have drawn attention to a rise in plasma digoxin concentration (PDC) when quinidine therapy was added to the medication and suggested that digoxin toxicity might ensue. In a retrospective study Leahey et al3 noted that such a rise in digoxin concentration might be responsible for an increase in the incidence of adverse reactions to digoxin. We report two cases in which quinidine given to digitalised patients caused digoxin toxicity. Blood for measuring digoxin and quinidine was drawn at least six hours after the last dose of the drugs. Digoxin was measured by radioimmunoassay and quinidine by a spectrofluorometric method.
Case reports
Case 1-A 69-year-old man with a history of ischaemic heart disease and myxoedema was admitted in left ventricular failure. He had been taking daily frusemide 160 mg, digoxin 0-125 mg, potassium supplements, and thyroxine 0-2 mg. The PDC was 1-1 nmol/l. His electrocardiogram (ECG) showed controlled atrial flutter-fibrillation. He responded to an increase in frusemide to 240 mg daily. Previous treatment was continued and on discharge the PDC was 1-0 nmol/l. Three weeks later he again went into left ventricular failure and his ECG showed fast atrial flutter-fibrillation. The PDC was again 1-0 nmol/l. Quinidine sulphate 250 mg 12-hourly was added to his regimen to control his dysrhythmia. He improved and was discharged, but was readmitted two weeks later with a five-day history of severe nausea and vomiting. The ECG showed atrial flutter-fibrillation with multiple ventricular premature beats. Plasma concentrations of digoxin and quinidine were 24 nmol/l and 10 yumol/l respectively. Both drugs were withdrawn and his symptoms resolved. Subsequently he was maintained on digoxin 0-125 mg daily and the PDC after one week was 0-8 nmol/l. Case 2-A 74-year-old woman had been admitted with an exacerbation of chronic obstructive airways disease and cor pulmonale. Her ECG showed atrial tachycardia with variable block. She was given prednisolone 3 mg, digoxin 0-125 mg, and frusemide 240 mg daily with potassium supplements. She developed large-bowel obstruction. Laparotomy revealed perforation of a sigmoid diverticulum, and a defunctioning transverse colostomy was performed. Postoperatively it was difficult to control her atrial tachycardia with digoxin alone although the PDC was 1 9 nmol/l on consecutive days. Quinidine sulphate 250 mg eight-hourly was added and her ECG reverted to sinus rhythm, but after five days multiple ventricular extrasystoles were noted. The plasma concentration of digoxin was 3-7 nmol/I and of quinidine 13-0 ismol/l. Digoxin was withdrawn and the extrasystoles resolved. She was eventually stabilised on digoxin 0-0625 mg daily and quinidine sulphate 250 mg 12-hourly, resulting in plasma drug concentrations of 1-2 nmol/l and 12-3 ,umol/l respectively.
Comment
In both cases the PDC rose sharply when quinidine was started. This caused symptoms and signs of digoxin toxicity which abated when digoxin was stopped. The conventional doses of quinidine used resulted in plasma drug concentrations within normal limits. In neither case could the rise in PDC be attributed to a deterioration in renal function, nor could other factors, such as compliance, be implicated. A number of changes in the pharmacokinetics of digoxin, including a reduction in its volume of distribution in the presence of quinidine, have recently been noted,4 and it has been shown that the most important effect of quinidine is to produce a two-fold decrease in the clearance of digoxin.5 In our cases routine measurement of the PDC brought this drug interaction to light, the symptoms and signs of digoxin toxicity correlating well with the plasma drug concentration. This suggests that measurement of the PDC may be particularly important when digoxin and quinidine are combined. When seen in March 1977 she was well and managing her job. She had no signs of heart failure and the prosthetic sounds were normal. Four weeks later she suddenly deyeloped severe chest pains and was admitted. She was in fast atrial fibrillation and was hypotensive. On auscultation the opening and closing clicks of the prosthesis could be heard and there were coarse crepitations at the lung bases. An electrocardiogram showed changes of an inferolateral myocardial infarction, and a chest radiograph showed cardiomegaly with pulmonary oedema (see figure) . A provisional diagnosis of coronary embolism and cardiogenic shock was made, and, despite conservative treatment, she died the following day, 21 hours after her acute collapse.
At necropsy the Bjork-Shiley prosthesis was completely detached and lay free in the left atrium. The sutures were intact around the prosthesis ring although they were slightly loose. The edges of the mitral annulus were frayed but no thrombus or vegetations were present. Histological examination showed no evidence of infection or calcification, and there were no myxoid changes.
Chest radiograph showing cardiomegaly, pulmonary oedema, and an abnormal position of the Bjork-Shiley mitral prosthesis.
This is the first reported case of complete dehiscence of a BjorkShiley prosthetic valve. Embolism of the poppet or occluder from a prosthetic valve presents with pulmonary oedema,. which is usually fatal within 36 hours,3 although, in some, surgical correction has been described.4 Incomplete prosthetic dehiscence, which is more common, has a less acute course and is associated with myxoid change,2 calcification,' or infection affecting the valve annulus.5 It is uncommon when the annulus is fibrosed from rheumatic heart disease.2 There was no evidence of these predisposing factors in our patient.
The lack of clinical features suggesting valve malfunction failed to alert us to the diagnosis, which, if recognised, might have led to surgical correction. We suggest that all patients with prosthetic valves presenting with pulmonary oedema should be carefully assessed for serious malfunction of the prosthesis.
We thank Mr D B Clarke for permission to report this case.
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Affinity chromatography of human ac-fetoprotein (AFP) on concanavalin-A-sepharose (con-A) yields two types of proteinlnamely, a con-A-binding fraction (type a), which adheres to the lectin, and a con-A-non-binding fraction (type b), which does not. Type b contributes only 2-6% of the fetal serum, whereas the proportion of type b in second-trimester amniotic fluid ranges from 15-45%.1 This difference is potentially useful for the early antenatal diagnosis of neural tube defects. In such cases the concentration of type b in the amniotic fluid is usually low, probably because of fetal serum leaking into the fluid.2 We have assessed the importance of this finding by testing a series of samples wrongly diagnosed from assays of total fluid AFP.
Methods and results
Amniotic fluid samples obtained by amniocentesis were assayed for total AFP concentration and stored at -20°C. Reassay after storage showed no changes in values. Affinity chromatography on con-A-sepharose (Pharmacia) was performed essentially as described,2 without the operator knowing the origin of the sample. Total AFP and the fraction passing through the column were measured using radioimmunoassay and the proportion of type b thus calculated.
Fifty-two samples of second-trimester amniotic fluid from normal singleton pregnancies were analysed. The mean proportion of type b detected was 25-6 % ± SD from mean 9-4 % (range 10 0-55-1 %). No consistent change in values occurred with advancing gestation. Four samples that had been diagnosed as abnormal because total AFP concentrations exceeded five standard deviations above the mean contained a normal proportion of type b -that is, over 10 % (table) . In a fifth sample both total AFP concentration and the proportion of type b suggested an abnormal fetus, which was not confirmed at birth. Six further samples from pregnancies complicated by spina bifida that had been missed on total AFP assay were diagnosed correctly from the proportion of type b detected-that is, under 10 %. In three of these six cases uncertainty over gestational age had contributed to the wrong diagnosis.
